Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science; Cancellation, 13856 [E6-3851]

Download as PDF 13856 Federal Register / Vol. 71, No. 52 / Friday, March 17, 2006 / Notices PMA No./Docket No. Applicant P040045/2005M–0504 Vistakon, Division of Johnson & Johnson Vision Care, Inc. II. Electronic Access DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science; Cancellation Food and Drug Administration, HHS. Notice. The Food and Drug Administration (FDA) is canceling the meeting of the Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science scheduled for April 18 and 19, 2006. This meeting was announced in the Federal Register of February 16, 2006 (71 FR 8307). SUMMARY: FOR FURTHER INFORMATION CONTACT: Mimi T. Phan, Center for Drug Evaluation and Research (HFD–21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, rm. 1093), Rockville, MD 20857, 301–827– 7001, FAX: 301–827–6776, e-mail: mimi.phan@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138(301–443–0572 in the Washington, DC area) code 3014512539. sroberts on PROD1PC70 with NOTICES Dated: March 10, 2006. Jason Brodsky, Acting Associate Commissioner for External Relations. [FR Doc. E6–3851 Filed 3–16–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclosed confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Training Programs (T32s and T35s). Date: May 26, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda, Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Charles Joyce, PhD, Scientific Review Administrator, Review Branch, NHLBI, National Institutes of Health, 6701 Rockledge Drive, Room 7196, Bethesda, MD 20892. 301–435–0288. cjoyce@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS). Dated: March 9, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2575 Filed 3–16–06; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 16:52 Mar 16, 2006 Jkt 208001 December 20, 2005 National Heart, Lung, and Blood Institutes; Notice of Closed Meeting BILLING CODE 4160–01–S BILLING CODE 4160–01–S VISTAKON (SENOFILCON A) CONTACT LENS, CLEAR AND VISIBILITY TINTED WITH UV BLOCKER National Institutes of Health Dated: March 7, 2006. Linda S. Kahan, Deputy Director, Center for Devices and Radiological Health. [FR Doc. E6–3850 Filed 3–16–06; 8:45 am] ACTION: Approval Date DEPARTMENT OF HEALTH AND HUMAN SERVICES Persons with access to the Internet may obtain the documents at https:// www.fda.gov/cdrh/pmapage.html. AGENCY: Trade Name PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 06–50, Review FRA DE–06– 005, Orofacial Pain. Date: April 20, 2006. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: H. George Hausch, Ph.D., Acting Director, 45 Center Drive, Natcher Building, Rm. 4AN44F, National Inst. of Dental & Craniofacial Research, National Institutes of Health, Bethesda, MD 20892. (301) 594–2904, george_hausch@nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 06–69, Review R21s. Date: April 24, 2006. Time: 3:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Lynn M. King, Ph.D., Scientific Review Administrator, Scientific Review Branch, 45 Center Dr., Rm. 4AN–32F, National Inst. of Dental & Craniofacial Research, National Institutes of Health, Bethesda, MD 20892–6402. (301) 594–5006, lynn.king@nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 06–59, Review RFA DE–06– 007. E:\FR\FM\17MRN1.SGM 17MRN1

Agencies

[Federal Register Volume 71, Number 52 (Friday, March 17, 2006)]
[Notices]
[Page 13856]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-3851]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Manufacturing Subcommittee of the Advisory Committee for 
Pharmaceutical Science; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is canceling the 
meeting of the Manufacturing Subcommittee of the Advisory Committee for 
Pharmaceutical Science scheduled for April 18 and 19, 2006. This 
meeting was announced in the Federal Register of February 16, 2006 (71 
FR 8307).

FOR FURTHER INFORMATION CONTACT: Mimi T. Phan, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, rm. 1093), Rockville, MD 20857, 
301-827-7001, FAX: 301-827-6776, e-mail: mimi.phan@fda.hhs.gov, or FDA 
Advisory Committee Information Line, 1-800-741-8138(301-443-0572 in the 
Washington, DC area) code 3014512539.

    Dated: March 10, 2006.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E6-3851 Filed 3-16-06; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.